Market snapshot: Natco Pharma Ltd (NATCOPHARM) has approved a massive capital allocation strategy for its South African operations. The company is set to invest ₹1400 crore into its subsidiary, primarily to facilitate the acquisition of an additional 13.25% stake in Adcock Ingram, a major pharmaceutical player in the region